postgrad News and Research

RSS

FDA grants seven years of marketing exclusivity for Octapharma’s Octagam 10%

Octapharma USA today announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has awarded seven years of marketing exclusivity for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis (DM).

31 Aug 2021

Achieving gender equality within global health

News-Medical spoke to Dr. Claire Bayntun about her incredible career in global health, and how we can achieve gender equality within healthcare settings.

28 Jun 2021

Placing students at the heart of Albumedix

Albumedix employ two postgraduates through the University of Nottingham placements scheme with companies for 3-6 months for up to 200 hours.

From Albumedix Ltd. 20 Aug 2019

postgrad News and Research

FDA grants seven years of marketing exclusivity for Octapharma’s Octagam 10%

Achieving gender equality within global health

Placing students at the heart of Albumedix

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News